Aziyo Biologics's total assets for Q2 2025 were $33.85M, a decrease of -13.87% from the previous quarter. ELUT total liabilities were $75.69M for the fiscal quarter, a -0.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.